SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-032205
Filing Date
2022-02-09
Accepted
2022-02-09 11:41:31
Documents
16
Period of Report
2022-02-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d276078d8k.htm   iXBRL 8-K 29292
2 EX-99.1 d276078dex991.htm EX-99.1 24419
3 EX-99.2 d276078dex992.htm EX-99.2 23832
7 GRAPHIC g276078g0209042618238.jpg GRAPHIC 2997
8 GRAPHIC g276078g0209043039284.jpg GRAPHIC 2997
  Complete submission text file 0001193125-22-032205.txt   221607

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20220209.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20220209_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20220209_pre.xml EX-101.PRE 10808
10 EXTRACTED XBRL INSTANCE DOCUMENT d276078d8k_htm.xml XML 3227
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 22605186
SIC: 2836 Biological Products, (No Diagnostic Substances)